"The stay was in response to requests from drugmakers Danco Laboratories and GenBioPro to restore access to mifepristone via teleprescribing and the mails."
"Louisiana argued the federal rules undermined its laws protecting unborn human life and caused it to spend Medicaid funds on emergency care for women harmed by mifepristone."
A recent stay was issued to clarify access to mifepristone via teleprescribing and mail, responding to requests from Danco Laboratories and GenBioPro. This order follows a 5th Circuit ruling that supported Louisiana's challenge against Biden administration rules that expanded mifepristone access. Louisiana contended that these federal rules conflicted with state laws protecting unborn life and resulted in increased Medicaid expenditures for emergency care related to mifepristone complications. Responses from involved parties are due by Thursday.
Read at Axios
Unable to calculate read time
Collection
[
|
...
]